Patents/Assignees

Mink Therapeutics, Inc.

4 patents in portfolio

US12391741utility2025
T Cell Receptors That Bind to Mixed Lineage Leukemia (mll)-specific Phosphopeptides and Methods of Use Thereof
0 cites
US11898165utility2024
Engineered Host Cells and Methods of Use Thereof
0 cites
US11718658utility2023
T Cell Receptors That Bind to Mixed Lineage Leukemia (mll)-specific Phosphopeptides and Methods of Use Thereof
0 cites
US11613764utility2023
T Cell Receptors That Bind to NY-ESO-1 and Methods of Use Thereof
0 cites